UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (7), p.2664-2674

2011

Volltextzugriff (PDF)

The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain

The Journal of pharmacology and experimental therapeutics, 2011-01, Vol.336 (1), p.223-233

2011

Volltextzugriff (PDF)

Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma

Drug metabolism and disposition, 2013-01, Vol.41 (1), p.33-39

2013

Volltextzugriff (PDF)

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

The Journal of pharmacology and experimental therapeutics, 2010-07, Vol.334 (1), p.147-155

2010

Volltextzugriff (PDF)

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy

Journal of immunotherapy (1997), 2013-11, Vol.36 (9), p.477-489

2013

Volltextzugriff (PDF)

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

Expert reviews in molecular medicine, 2011-05, Vol.13, p.e17-e17, Article e17

2011

Volltextzugriff (PDF)

Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier

Journal of Cerebral Blood Flow & Metabolism, 2013-01, Vol.33 (1), p.13-21

2013

Volltextzugriff (PDF)

Increasing the efficacy of tumor cell vaccines by enhancing cross priming

Cancer letters, 2012-12, Vol.325 (2), p.155-164

2012

Volltextzugriff (PDF)

Profound impairment of adaptive immune responses by alkylating chemotherapy

The Journal of immunology (1950), 2013-06, Vol.190 (12), p.6259-6268

2013

Volltextzugriff (PDF)

Identification of myeloid derived suppressor cells in dogs with naturally occurring cancer

PloS one, 2012-03, Vol.7 (3), p.e33274-e33274

2012

Volltextzugriff (PDF)

Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors

Journal of immunotherapy (1997), 2011-04, Vol.34 (3), p.264-269

2011

Volltextzugriff (PDF)

Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents

Molecular cancer therapeutics, 2012-10, Vol.11 (10), p.2183-2192

2012

Volltextzugriff (PDF)

Role of Type 1 IFNs in Antiglioma Immunosurveillance-Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

Clinical cancer research, 2010-07, Vol.16 (13), p.3409-3419

2010

Volltextzugriff (PDF)

De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2), p.431-439

2009

Volltextzugriff (PDF)

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

Journal of controlled release, 2013-11, Vol.171 (3), p.280-287

2013

Volltextzugriff (PDF)

Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses

PloS one, 2015-05, Vol.10 (5), p.e0125565-e0125565

2015

Volltextzugriff (PDF)

GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α

Cancer research (Chicago, Ill.), 2013-11, Vol.73 (21), p.6413-6423

2013

Volltextzugriff (PDF)

Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy

Journal of neuro-oncology, 2007-06, Vol.83 (2), p.121-131

2007

Volltextzugriff (PDF)

Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system

Blood, 2005-04, Vol.105 (7), p.2691-2698

2005

Volltextzugriff (PDF)

Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial

PloS one, 2010-06, Vol.5 (6), p.e11074-e11074

2010

Volltextzugriff (PDF)

Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma

Molecular therapy, 2005-11, Vol.12 (5), p.778-788

2005

Volltextzugriff (PDF)

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Cell reports (Cambridge), 2017-04, Vol.19 (3), p.668-668

2017

Volltextzugriff (PDF)

Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis

Clinical cancer research, 2008-09, Vol.14 (17), p.5484-5493

2008

Volltextzugriff (PDF)

Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas

Scientific reports, 2019-01, Vol.9 (1), p.358-358, Article 358

2019

Volltextzugriff (PDF)

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Cell reports (Cambridge), 2017-01, Vol.18 (1), p.23-31

2017

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(77)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain

Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

Immunologic Privilege in the Central Nervous System and the Blood–Brain Barrier

Increasing the efficacy of tumor cell vaccines by enhancing cross priming

Profound impairment of adaptive immune responses by alkylating chemotherapy

Identification of myeloid derived suppressor cells in dogs with naturally occurring cancer

Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors

Active efflux of Dasatinib from the brain limits efficacy against murine glioblastoma: broad implications for the clinical use of molecularly targeted agents

Role of Type 1 IFNs in Antiglioma Immunosurveillance-Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses

GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α

Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy

Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system

Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial

Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis

Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Suchergebnisse filtern